If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.70
Bid: 49.80
Ask: 49.95
Change: -0.80 (-1.58%)
Spread: 0.15 (0.301%)
Open: 50.00
High: 50.60
Low: 49.30
Prev. Close: 50.50
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM, Annual Report, Scrip Dividend

6 May 2021 18:13

RNS Number : 8454X
IP Group PLC
06 May 2021
 

FOR RELEASE ON

06 May 2021

 

IP Group plc - 2020 Annual Report; Notice of AGM; Scrip Dividend Scheme

 

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces that it has published its Annual Report and Accounts for the year ended 31 December 2020.

 

In compliance with Listing Rule 9.6.3, a copy of the following documents will shortly be available for inspection at www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

- Annual Report and Accounts for the year ended 31 December 2020 ("2020 ARA"); and

- Notice of 2021 Annual General Meeting ("2021 AGM Notice") containing the terms and conditions of the Scrip Dividend Scheme, including the scrip dividend in respect of the 2020 final dividend ("Scrip Dividend Scheme Terms and Conditions").

Printed copies of these documents together with the Form of Proxy for use in connection with the 2021 Annual General Meeting and a Scrip Dividend Mandate Form have been posted to shareholders who have requested hard copies. An electronic copy of the 2020 ARA is available on the Investor Relations section of the IP Group website at www.ipgroupplc.com/investor-relations. Copies of the 2021 AGM Notice incorporating the Scrip Dividend Scheme Terms and Conditions, the Scrip Dividend Mandate Form and the changes to the Company's articles of association proposed for approval at the 2021 AGM are also available electronically on the IP Group website at https://www.ipgroupplc.com/investor-relations/shareholder-information/agm.

The 2021 Annual General Meeting will be held at 10.00am on 09 June 2020 at the Company's offices at The Walbrook Building, 25 Walbrook, London, EC4N 8AF.

Given the UK Government's current COVID-19 guidelines, the Board has taken the decision to hold the 2021 AGM as a closed meeting with the minimum attendance required to form a quorum (being two shareholders). No other shareholders will be permitted to physically attend the meeting. The Company requests that shareholders submit their votes by proxy either electronically or by post, in accordance with the instructions in the 2021 AGM Notice. The Company is taking these precautionary measures to safeguard its shareholders' and employees' health and make the AGM as safe and efficient as possible.

The Board greatly values the opportunity to meet its shareholders and as such we currently intend to hold a webinar immediately after the AGM at which a Group update will be provided and shareholders will be able to ask questions of the Board, both in advance and live on the day. Details of the time of the webinar and how to access it will be made available on the Group's website nearer the date of the AGM at www.ipgroupplc.com/investor-relations/shareholder-information/agm .

The Board will keep these AGM arrangements under review and the Board will update shareholders via the Regulatory News Service ("RNS") as appropriate, with any such announcements also uploaded to the Company's website (https://www.ipgroupplc.com/investor-relations/shareholder-information/agm). The Company encourages shareholders to check its website regularly for the latest information on the arrangements for the AGM.

 For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/

+44 (0) 7979 853802

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOABRGDUBBGDGBL
Date   Source Headline
5th Jan 20245:02 pmRNSTransaction in Own Shares
4th Jan 20245:48 pmRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
22nd Dec 20237:10 amRNSTop 20 portfolio company funding round
20th Dec 20236:20 pmRNSTransaction in Own Shares
19th Dec 20235:44 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSShare buyback programme
14th Nov 20237:11 amRNSAutifony signs deal with Jazz for up to $770m
26th Oct 20236:10 pmRNSHolding(s) in Company
12th Oct 202310:20 amRNSWebinar on ESG & Impact
28th Sep 20234:28 pmRNSDirector/PDMR Shareholding; SAYE scheme
8th Aug 202310:00 amRNSTechnology trends webinar on AI
2nd Aug 20237:00 amRNSIP Group half-yearly results
13th Jul 20235:11 pmRNSDirector Declaration
12th Jul 20231:41 pmRNSTR-1: form for notification of major holdings
30th Jun 202310:23 amRNSTotal Voting Rights
29th Jun 20236:24 pmRNSDirector/PDMR Shareholding
28th Jun 202311:31 amRNSNotice of Results
26th Jun 202312:41 pmRNSDirector Declaration
15th Jun 20231:19 pmRNSResult of AGM
15th Jun 20237:00 amRNSAGM Statement
8th Jun 20238:51 amRNSLife Sciences update event
7th Jun 202311:00 amRNSIP Group plc - TR1 form
31st May 20232:34 pmRNSTotal Voting Rights
12th May 20231:26 pmRNSDirector Declaration
10th May 202312:11 pmRNSDirector/PDMR Shareholding
3rd May 202310:56 amRNSDirector Declaration
28th Apr 20233:21 pmRNSTotal Voting Rights
20th Apr 20235:00 pmRNSNotice of AGM, Annual Report
18th Apr 20233:23 pmRNSRSP & DBSP awards; Director/PDMR shareholding
15th Mar 20239:31 amRNSInvestor presentation
13th Mar 20239:00 amRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSNo direct deposits or credit facilities with SVB
8th Mar 20237:00 amRNSIP Group plc - Annual Results
2nd Mar 20233:25 pmRNSTR-1
21st Feb 20237:00 amRNSAMSL Aero's all-electric aircraft maiden flight
10th Feb 20239:55 amRNSNotice of Results
31st Jan 202310:00 amRNSTotal Voting Rights
30th Jan 20237:00 amRNSStatement re press speculation
24th Jan 20231:18 pmRNSForm 8.3 - Mirriad Advertising plc
18th Jan 20237:00 amRNSDirectorate Change
11th Jan 20237:00 amRNSPortfolio company Oxbotica raises $140m Series C
3rd Jan 202311:48 amRNSTotal Voting Rights
12th Dec 20224:58 pmRNSAGM post-meeting shareholder engagement update
7th Dec 20224:39 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSIstesso announces FDA Fast Track for MBS2320
2nd Dec 202211:38 amRNSPortfolio company funding leads to £36m gain
30th Nov 202210:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.